首页> 外文OA文献 >Comparison of Everolimus- and Sirolimus-Eluting Stents in Patients With Long Coronary Artery Lesions A Randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) Trial

【2h】

Comparison of Everolimus- and Sirolimus-Eluting Stents in Patients With Long Coronary Artery Lesions A Randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) Trial

机译：长冠状动脉病变患者使用依维莫司和西罗莫司洗脱支架的比较-随机LONG-DES-III（药物洗脱支架-III经皮治疗长处天然冠状动脉病变）试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Park Duk-Woo; Kim Young-Hak; Song Hae-Geun; Ahn Jung-Min; Kim Won-Jang; Lee Jong-Young; Kang Soo-Jin; Lee Seung-Whan; Lee Cheol Whan; Park Seong-Wook; Yun Sung-Cheol; Seung Ki-Bae; Yang Tae-Hyun; Lee Sang-Gon; Lee Jae-Hwan; Seong In-Whan; Cheong Sang-Sig; Lee Bong-Ki; Lee Nae-Hee; Lee Se-Whan; Lee Seung-Wook; Lee Keun; Kim Hyun-Sook; Jeon Doo-Soo; Kim Min-Kyu; Nah Deuk-Young; Tahk Seung-Jea; Park Seung-Jung;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) Trial. [J] . Park DW, Kim YH, Song HG, JACC. Cardiovascular interventions . 2011,第10期

机译：长冠状动脉病变患者使用依维莫司和西罗莫司洗脱支架的比较：随机LONG-DES-III（药物洗脱支架-III经皮治疗LONG天然冠状动脉病变）试验。
2. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). [J] . Kandzari DE, Mauri L, Popma JJ, JACC. Cardiovascular interventions . 2011,第5期

机译：佐他莫司和西罗莫司洗脱支架的近期临床疗效。 ENDEAVOR III（美敦力努力药物（ABT-578）洗脱冠状动脉支架系统与赛诺莫司洗脱冠状动脉支架系统在De Novo天然冠状动脉病变中的随机对照试验）的5年随访。
3. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). [J] . Kandzari DE, Mauri L, Popma JJ, JACC. Cardiovascular interventions . 2011,第5期

机译：佐他莫司和西罗莫司洗脱支架的近期临床疗效。 ENDEAVOR III（美敦力努力药物（ABT-578）洗脱冠状动脉支架系统与赛诺莫司洗脱冠状动脉支架系统在De Novo天然冠状动脉病变中的随机对照试验）的5年随访。
4. Efficacy of Drug-Eluting Stents in the Treatment of Coronary Artery Bypass Graft Lesions [C] . J. Garcia-Tejada, F. Hernandez, M. Velazquez, International Congress on Coronary Artery Disease . 2007

机译：药物洗脱支架在冠状动脉旁路移植物病变治疗中的疗效
5. A comparison of selected preoperative coronary artery disease risk factors in patients 40 years or younger and patients over 40 years undergoing coronary artery bypass graft surgery. [D] . Frye, Laurie Perry. 2002

机译：比较40岁以下的患者和40岁以上进行冠状动脉搭桥术的患者的术前选择的冠心病危险因素。
6. Fast Track: A randomized prospective intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial [O] . Shigeru Saito, Mariano Valdes-Chavarri, Gert Richardt, -1

机译：快速通道：生物可吸收性聚合物西罗莫司洗脱冠状动脉支架系统的随机前瞻性洲际评估：CENTURY II（新的Terumo药物洗脱冠状动脉支架系统在冠状动脉疾病患者治疗中的临床评估）试验
7. Clinical Follow-Up 3 Years After Everolimus- and Paclitaxel-Eluting Stents A Pooled Analysis From the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System EECSS in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) Randomized Trials [O] . Caixeta Adriano, Lansky Alexandra J., Serruys Patrick W., 2010

机译：依维莫司和紫杉醇洗脱支架3年后的临床随访SPIRIT II（XIENCE V依维莫司洗脱冠状动脉支架系统治疗De Novo天然冠状动脉病变患者的临床评价）的汇总分析（研究装置XIENCE V依维莫司洗脱冠状动脉支架系统EECSS在从头开始治疗原发性冠状动脉病变的患者中的临床评价）随机试验

Comparison of Everolimus- and Sirolimus-Eluting Stents in Patients With Long Coronary Artery Lesions A Randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) Trial

著录项

相似文献

相关主题

期刊订阅